<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343003">
  <stage>Registered</stage>
  <submitdate>31/05/2011</submitdate>
  <approvaldate>1/06/2011</approvaldate>
  <actrnumber>ACTRN12611000559910</actrnumber>
  <trial_identification>
    <studytitle>The impact of rotavirus vaccine introduction in SA</studytitle>
    <scientifictitle>An observational, cross sectional, cohort study to assess the impact of rotavirus vaccine introduction on severe gastroenteritis in South Australian children.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>severe gastroenteritis</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>introduction of rotavirus vaccine onto the National Immunisation Program in Australia.  Rotavirus vaccine (Rotateq in SA) was introduced to be administered at 2,4 and 6 months of for infants born in Australia from 01May2011.  This study is observational and examined the changes in severe rotavirus and severe gastroenteritis disease before and after the introduction of the vaccine.  The study period is 01May2005 - 30April2011.  Information regarding severe gastroneteritis was obtained from health information portal statistics and review of medical admission case notes for children born pre and post introduction of the rotavirus vaccine onto the National Immunisation Program.</interventions>
    <comparator>cohort prior to introduction of the rotavirus vaccine onto the National Immunisation Program in Australia.  Data is gathered from Health Information Portal statistics and review of medical admission case notes for the period 01May2005-30April2007.</comparator>
    <control>Historical</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Prevalence of rotavirus coded hospital admissions</outcome>
      <timepoint>Period 01May2005-30Apr2007 (pre vaccine introduction) and 01May2009-30Apr2011 (post vaccine introduction)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Prevalence of all-cause gastroenteritis coded hospital admissions</outcome>
      <timepoint>Period 01May2005-30Apr2007 (pre vaccine introduction) and 01May2009-30Apr2011 (post vaccine introduction)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>% severe (scored by severity index) of rotavirus coded hospital admissions</outcome>
      <timepoint>Period 01May2005-30Apr2007 (pre vaccine introduction) and 01May2009-30Apr2011 (post vaccine introduction)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>aged 0-less than 6 years of age
admitted to hospital with ICD10-AM separation codes consistent with rotaviral infection or gastroenteritis of any cause.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>6</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>nosocomial irotaviral nfections (defined as onset &gt;48 hours post admission date) will be reported separately in the severity analysis</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Both</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Children, Youth and Women's health Service</primarysponsorname>
    <primarysponsoraddress>Children, Youth and Women's Health Service
72 King William Road
North Adelaide SA 5006</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Vaccinology and Immunology Research Trials Unit</fundingname>
      <fundingaddress>Discipline of Paediatrics, 
Women's and Children's Hospital
Children, Youth and Women's Health Service
72 King William Road
North Adelaide SA 5006</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This project aims to assess the impact of rotavirus vaccine introduction on severe gastroenteritis in South Australian children.  Prevalence of rotavirus coded hospitalisations and all-cause gastrenteritis hospitalisations will be compared for a two year period prior to introduction of the vaccine and a two year period following introduction of the vaccine.  Severity of rotavirus coded admissions during the periods will also be assessed.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Children, Youth and Women's Health Service Human Research Ethics Committee</ethicname>
      <ethicaddress>Children, Youth and Women's Health Service
Human Research Ethics Committee
72 King William Road
North Adelaide SA 5006</ethicaddress>
      <ethicapprovaldate>1/05/2009</ethicapprovaldate>
      <hrec>322A</hrec>
      <ethicsubmitdate>8/04/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Helen Marshall</name>
      <address>Discipline of Paediatrics
Women's and Children's Hospital
72 King William Rd, North Adelaide, SA 5006</address>
      <phone>+61 8 8161 8115</phone>
      <fax />
      <email>helen.marshall@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Helen Marshall</name>
      <address>Discipline of Paediatrics
Women's and Children's Hospital
72 King William Rd, North Adelaide, SA 5006</address>
      <phone>+61 8 8161 8115</phone>
      <fax />
      <email>helen.marshall@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michelle Clarke</name>
      <address>Discipline of Paediatrics
Women's and Children's Hospital
72 King William Rd, North Adelaide, SA 5006</address>
      <phone>+61 8 8161 7991</phone>
      <fax />
      <email>helen.marshall@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>